HCA Healthcare, Inc. $HCA Shares Acquired by Royal London Asset Management Ltd.

Key Points

• Royal London Asset Management increased its HCA Healthcare position by 4.7% in the second quarter, adding 27,282 shares to own 604,401 shares valued at approximately $235.7 million. Institutional investors collectively own 62.73% of the company.
• Analyst sentiment remains positive but mixed, with HCA holding a “Moderate Buy” consensus rating and an average price target of $462.64. Recent target-price reductions from several firms were offset by Truist’s “buy” rating and $495 target.
• HCA reported quarterly EPS of $7.59, narrowly exceeding estimates, while revenue rose 8.7% year over year to $20.23 billion. The company also declared a quarterly dividend of $0.78 per share, equivalent to a 0.7% annualized yield.

Royal London Asset Management Ltd. lifted its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 4.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 604,401 shares of the company's stock after acquiring an additional 27,282 shares during the period. Royal London Asset Management Ltd. owned 0.28% of HCA Healthcare worth $235,650,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also modified their holdings of the company. Sumitomo Life Insurance Co. lifted its stake in shares of HCA Healthcare by 1.0% in the fourth quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company's stock worth $946,000 after buying an additional 20 shares in the last quarter. MJP Associates Inc. ADV boosted its holdings in shares of HCA Healthcare by 2.9% during the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company's stock worth $350,000 after purchasing an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC increased its holdings in shares of HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company's stock valued at $140,000 after purchasing an additional 21 shares during the last quarter. Anchyra Partners LLC boosted its stake in HCA Healthcare by 3.7% during the first quarter. Anchyra Partners LLC now owns 587 shares of the company's stock worth $278,000 after buying an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd raised its holdings in shares of HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company's stock worth $1,833,000 after acquiring an additional 22 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

Wall Street Analyst Weigh In

HCA has been the topic of a number of analyst reports. Robert W. Baird reduced their target price on shares of HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating on the stock in a research note on Monday, July 27th. Jefferies Financial Group set a $450.00 price target on shares of HCA Healthcare in a research report on Tuesday, July 14th. Barclays lowered their price objective on HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating for the company in a research report on Monday, July 27th. Wall Street Zen lowered HCA Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday, May 2nd. Finally, Truist Financial reduced their price objective on shares of HCA Healthcare from $535.00 to $495.00 and set a "buy" rating on the stock in a report on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $462.64.

HCA Healthcare Trading Down 0.4%

Shares of NYSE HCA opened at $417.57 on Friday. The stock has a fifty day simple moving average of $401.08 and a 200-day simple moving average of $441.46. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The stock has a market capitalization of $90.40 billion, a PE ratio of 13.98, a PEG ratio of 1.46 and a beta of 1.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to analysts' expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare's revenue for the quarter was up 8.7% on a year-over-year basis. During the same period last year, the business posted $6.84 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is currently 10.45%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source